InnovAge
INNV
$3.80
Share price
-4.76%
Change (1 day)
-38.31%
Change (1 year)
Categories
InnovAge (INNV) - Cash on Hand
Cash on Hand as of December 2023 : $98.77 M
According to InnovAge's latest financial reports the company has $98.77 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
InnovAge - Cash on Hand chart (from 2020 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-06-30 | $0.17 B | -5.95% |
| 2022-06-30 | $0.18 B | -8.46% |
| 2021-06-30 | $0.20 B | 78.44% |
| 2020-06-30 | $0.11 B | 89.24% |
| 2019-06-30 | $59.66 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Merck MRK | $7.09 B | 7,081.26% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | $29.73 M | -69.89% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | $9.38 M | -90.50% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $2.46 B | 2,395.29% | 🇮🇪 Ireland |